In addition, classic cancer driver genes identified in other cancers were also identified as SMGs in this study, including ATM (3.45%, 12/348), BRCA2 (2.01%, 7/348), and MLLT4 (2.01%, 7/348). This evidence concerns the gene ATM and cancer.